Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 20;15(1):2534.
doi: 10.1038/s41598-025-87014-7.

Real-time trajectory imaging of alpha particles emitted from actinium-225 and its daughter radionuclides

Affiliations

Real-time trajectory imaging of alpha particles emitted from actinium-225 and its daughter radionuclides

Seiichi Yamamoto et al. Sci Rep. .

Abstract

In targeted alpha-particle therapy, actinium-225 (Ac-225) has emerged as a radionuclide of potential, driving extensive efforts to develop innovative radiopharmaceuticals. High-resolution imaging of alpha particles is required for precisely detecting alpha-emitting radionuclides in cellular environments and small organs. Here, we report real-time trajectory imaging of alpha particles emitted by Ac-225 and its daughter radionuclides, utilizing an alpha particle trajectory imaging system. This system incorporates a magnification unit, a cooled electron-multiplying charge-coupled device (EM-CCD) camera, and a Ce-doped Gd3Al2Ga3O12 (GAGG) scintillator. Alpha particles were projected onto the GAGG scintillator, producing magnified images that were captured at 100 ms intervals. We successfully tracked particle trajectories with varying lengths and intensities for 4 different alpha particles emitted from Ac-225 and its daughter radionuclides with a spatial resolution of 1.0 μm. Notably, we achieved the imaging of sequentially emitted trajectories from Fr-221 and its decay product At-217, characterized by short decay intervals, along with the extended trajectories of high-energy alpha particles emitted by Po-213. These results demonstrate that high-resolution trajectory imaging, integrated with temporal and energy information, offers profound insights into the real-time behavior of Ac-225 and its daughter radionuclides within living cells or tissue sections, thereby driving advancements in targeted alpha-particle therapy.

Keywords: Actinium-225; Alpha particles; Imaging, energy spectrum; Trajectory.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Half-life and alpha particle energies of Ac-225 and daughter radionuclides.
Fig. 2
Fig. 2
Schematic drawing of developed high-resolution alpha-particle imaging system (A) and photo during imaging (B).
Fig. 3
Fig. 3
Energy spectra measurement of alpha-particles emitted from Ac-225 and its daughter radionuclides measured with silicon charged-particle detector.
Fig. 4
Fig. 4
Two composite images each created by summing 10 individual frames captured over 100 ms with a 40× lens.
Fig. 5
Fig. 5
Two of measured images containing alpha particles from Po-214 (8.4 MeV) (indicated with arrow) measured with 100 ms and 40 x lens (A) and depth (B) and lateral profiles (C) of alpha particles.
Fig. 6
Fig. 6
Alpha particle trajectory images contained alpha particles from Fr-221 (6.4 MeV) and At-217 (7.1 MeV) emitted almost simultaneously with “V” shape (indicated in arrow) measured with 100 ms and 40 x lens.
Fig. 7
Fig. 7
Measured image with 20 × lens of alpha-particles emitted from Ac-225 and its daughter radionuclides in GAGG plate (A) and simulated image (B).
Fig. 8
Fig. 8
Energy spectra estimated from measured with 20 × lens of alpha-particles emitted from Ac-225 and its daughter radionuclides in GAGG plate (A) and smoothed energy spectra calculated by simulation (B).

Similar articles

Cited by

References

    1. Jang, A., Kendi, A. T., Johnson, G. B., Halfdanarson, T. R. & Sartor, O. Targeted alpha-particle therapy: A review of current trials. Int. J. Mol. Sci.24(14), 11626 (2023). - PMC - PubMed
    1. Kratochwil, C. et al. 225Ac-PSMA-617 for PSMA-targeted α-radiation therapy of metastatic castration-resistant prostate cancer. J. Nucl. Med.57, 1941–1944 (2016). - PubMed
    1. Albert et al. Targeted alpha-particle therapy: A review of current trials. Int. J. Mol. Sci.24, 11626 (2023). - PMC - PubMed
    1. Hassan, M. et al. A review of recent advancements in Actinium-225 labeled compounds and biomolecules for therapeutic purposes. Chem. Biol. Drug Des.102(5), 1276–1292 (2023). - PubMed
    1. Kodaira, S. et al. Validating α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors. PLoS ONE12(6), e0178472 (2017). - PMC - PubMed

Publication types

LinkOut - more resources